Study of the safety and efficacy of daily tenofovir [disoproxil fumarate] to prevent HIV infection among injection drug users in Bangkok, Thailand

Trial Profile

Study of the safety and efficacy of daily tenofovir [disoproxil fumarate] to prevent HIV infection among injection drug users in Bangkok, Thailand

Completed
Phase of Trial: Phase II/III

Latest Information Update: 09 Feb 2015

At a glance

  • Drugs Tenofovir disoproxil fumarate (Primary)
  • Indications HIV infections
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms Bangkok Tenofovir; BTS
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 14 May 2014 Results on renal functions published in the Clinical Infectious Diseases.
    • 03 Jul 2013 Results on patient compliance presented at the 7th International AIDS Society Conference on HIV Pathogenesis and Treatment.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top